Tumor necrosis factor-alpha (
TNFalpha) critically regulates several cellular functions during monocyte/macrophage differentiation. We therefore investigated during the
phorbol ester (phorbol 12-myristate 13-acetate (PMA))-induced monocyte/macrophage differentiation of the human HL-60
leukemia cells, if
TNFalpha contributed to
plasminogen activator inhibitor type-1 (PAI-1) synthesis that is initiated by a
protein kinase Cbeta-
extracellular signal-regulated kinase 2-dependent pathway (Lopez, S., Peiretti, F.,
Morange, P., Laouar, A., Fossat, C., Bonardo, B., Huberman, E., Juhan-Vague, I., and Nalbone, G. (1999) Thromb. Haemostasis 81, 415-422). Following PMA treatment, the level of
TNFalpha mRNA strongly increased and appeared earlier than
PAI-1 mRNA. An anti-
TNFalpha antibody significantly inhibited the PMA-induced
PAI-1 mRNA and
protein levels. The recombinant human
TNFalpha, which is inactive on native HL-60 cells in terms of
PAI-1 synthesis, optimally potentiates it once HL-60 cells are committed into the differentiation process. The use of 1) the HL-525 cell line, a clone issued from HL-60 cells rendered resistant to PMA-induced differentiation, and 2) the transforming growth factorbeta-1/
vitamin D3 differentiative mixture confirmed the relationships between the induction of differentiation and the potency of
TNFalpha to up-regulate PAI-1 synthesis. In conclusion, we showed that during the induction of monocyte/macrophage differentiation,
TNFalpha and PAI-1 gene expressions are activated and that synthesized
TNFalpha up-regulates and prolongs, in an autocrine manner, the synthesis of PAI-1.